QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Jonathan M. Pratt
CEOJonathan M. Pratt
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
9.01B
Market cap9.01B
Price-Earnings ratio
22.19
Price-Earnings ratio22.19
Dividend yield
0.80%
Dividend yield0.80%
Average volume
1.56M
Average volume1.56M
High today
$43.92
High today$43.92
Low today
$42.66
Low today$42.66
Open price
$43.50
Open price$43.50
Volume
2.67M
Volume2.67M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $43.71. The company's market cap stands at 9.01B, with a P/E ratio of 22.19 and a dividend yield of 0.80%.

During the trading session on 2026-09-23, QIAGEN(QGEN) shares reached a daily high of $43.92 and a low of $42.66. At a current price of $43.71, the stock is +2.5% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 2.67M, compared to an average daily volume of 1.56M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 2h
BlackRock Builds 11.47% Stake in Qiagen, AFM Filing Shows

Qiagen ( (QGEN) ) has issued an announcement. Qiagen disclosed that the Dutch financial regulator AFM has notified the company of a substantial shareholding in...

Simply Wall St 4d
How Investors May Respond To Qiagen Earnings Beat

Qiagen has introduced QIAsymphony Connect, an automated clinical nucleic acid extraction platform with regulatory clearances in the US and Europe, alongside sec...

How Investors May Respond To Qiagen Earnings Beat
Simply Wall St 6d
Qiagen Could Be 2% Undervalued After QIAsymphony Launch And Outlook Reaffirmed

Qiagen (QGEN) has drawn fresh attention after launching its QIAsymphony Connect automation platform, securing regulatory clearances in the US and Europe while m...

Qiagen Could Be 2% Undervalued After QIAsymphony Launch And Outlook Reaffirmed

Analyst ratings

59%

of 22 ratings
Buy
40.9%
Hold
59.1%
Sell
0%

More QGEN News

TipRanks 6d
Qiagen attracts interest from KKR, Advent, TPG, Manager Magazin reports

Qiagen (QGEN) is attracting interest from multiple private equity firms, including KKR (KKR), EQT, Advent, TPG (TPG), and Bain Capital, with expectations that s...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.